These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 21233695)

  • 1. Influence of predictive modeling in implementing optimal heart failure therapy.
    Prasad H; Sra J; Levy WC; Stapleton DD
    Am J Med Sci; 2011 Mar; 341(3):185-90. PubMed ID: 21233695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Gheorghiade M; Inge PJ; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Circ Heart Fail; 2010 Sep; 3(5):596-605. PubMed ID: 20634483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction: A Systematic Review and Network Meta-Analysis.
    Tseng AS; Kunze KL; Lee JZ; Amin M; Neville MR; Almader-Douglas D; Killu AM; Madhavan M; Cha YM; Asirvatham SJ; Friedman PA; Gersh BJ; Mulpuru SK
    Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e006951. PubMed ID: 31159582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure: clinical problem and management issues.
    Nicklas JM; Bleske BE; Van Harrison R; Hogikyan RV; Kwok Y; Chavey WE
    Prim Care; 2013 Mar; 40(1):17-42. PubMed ID: 23402460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
    Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
    Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure.
    Stewart GC; Kittleson MM; Patel PC; Cowger JA; Patel CB; Mountis MM; Johnson FL; Guglin ME; Rame JE; Teuteberg JJ; Stevenson LW
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27834198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications.
    Atwater BD; Dai D; Allen-Lapointe NM; Al-Khatib SM; Zimmer LO; Sanders GD; Peterson ED
    Am Heart J; 2012 Nov; 164(5):750-755.e1. PubMed ID: 23137506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
    Shah R; Wang Y; Foody JM
    Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort.
    Morbach C; Wagner M; Güntner S; Malsch C; Oezkur M; Wood D; Kotseva K; Leyh R; Ertl G; Karmann W; Heuschmann PU; Störk S
    BMC Cardiovasc Disord; 2017 May; 17(1):108. PubMed ID: 28476146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons Learned and Insights Gained in the Design, Analysis, and Outcomes of the COMPANION Trial.
    Bristow MR; Saxon LA; Feldman AM; Mei C; Anderson SA; DeMets DL
    JACC Heart Fail; 2016 Jul; 4(7):521-535. PubMed ID: 27289408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of conservative management vs. assist device implantation in patients with advanced refractory heart failure.
    Adlbrecht C; Hülsmann M; Wurm R; Eskandary F; Neuhold S; Zuckermann A; Bojic A; Strunk G; Pacher R
    Eur J Clin Invest; 2016 Jan; 46(1):34-41. PubMed ID: 26540663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.
    Maggioni AP; Anker SD; Dahlström U; Filippatos G; Ponikowski P; Zannad F; Amir O; Chioncel O; Leiro MC; Drozdz J; Erglis A; Fazlibegovic E; Fonseca C; Fruhwald F; Gatzov P; Goncalvesova E; Hassanein M; Hradec J; Kavoliuniene A; Lainscak M; Logeart D; Merkely B; Metra M; Persson H; Seferovic P; Temizhan A; Tousoulis D; Tavazzi L;
    Eur J Heart Fail; 2013 Oct; 15(10):1173-84. PubMed ID: 23978433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure medications prescribed at discharge for patients with left ventricular assist devices.
    Shreibati JB; Sheng S; Fonarow GC; DeVore AD; Yancy CW; Bhatt DL; Schulte P; Peterson ED; Hernandez A; Heidenreich PA
    Am Heart J; 2016 Sep; 179():99-106. PubMed ID: 27595684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for heart transplantation.
    Sartipy U; Goda A; Yuzefpolskaya M; Mancini DM; Lund LH
    Am Heart J; 2014 Sep; 168(3):325-31. PubMed ID: 25173544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart Failure Due to Reduced Ejection Fraction: Medical Management.
    Chavey WE; Hogikyan RV; Van Harrison R; Nicklas JM
    Am Fam Physician; 2017 Jan; 95(1):13-20. PubMed ID: 28075105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current challenges in the management of heart failure.
    Komajda M
    Circ J; 2015; 79(5):948-53. PubMed ID: 25877621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
    Bristow MR; Saxon LA; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; DeMets D; White BG; DeVries DW; Feldman AM;
    N Engl J Med; 2004 May; 350(21):2140-50. PubMed ID: 15152059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General practitioners' adherence to chronic heart failure guidelines regarding medication: the GP-HF study.
    Hirt MN; Muttardi A; Helms TM; van den Bussche H; Eschenhagen T
    Clin Res Cardiol; 2016 May; 105(5):441-50. PubMed ID: 26552905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.